ClinicalTrials.gg
Drug

Thyrotropin Alfa clinical trials

studies test it
15
open now
1
in phase 3
6
first study started
1997

How each study uses Thyrotropin Alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Thyrotropin Alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Nov 1998 · THYROGEN · BLA 020898 (FDA, Drugs@FDA)
European Union
9 Mar 2000 · Thyrogen · EMEA/H/C/000220 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

rhTSH
5
Thyrogen
3
Recombinant human thyrotropin (Thyrogen)
2

Other names

Thyrotropin alpha
1

Studies by the year they started

15 studies that test it; most in 2006 (3)

Studies that test Thyrotropin Alfa, by start year
YearStudies
19971
20011
20021
20063
20071
20081
20121
20171
20192
20201
20212

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
6
Phase 3
6
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 8

Suzhou Zelgen Biopharmaceuticals Co.,Ltd (4) · Genzyme, a Sanofi Company (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · University College, London (1) · Genexine, Inc. (1) · University of Colorado, Denver (1) · Steen Bonnema (1) · Copenhagen University Hospital at Herlev (1)

Often tested with

Tested in the same studies.

Iodide ion i-131 (1) · Pre-Procedure Thyroid Hormone Therapy Withdrawal (1) · IODE 131 (1)

Studies

Open first, then newest update. How each study uses Thyrotropin Alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Given beside what is tested · 6 — Thyrotropin Alfa is usual care or a partner of the new treatment

Codes

What other systems call Thyrotropin Alfa · ClinicalTrials.gg INT008918

  • MeSH (NLM) D057073Thyrotropin AlfaConfirmed ClinicalTrials.gov, Wikidata
  • UNII (FDA) AVX3D5A4LMTHYROTROPIN ALFAConfirmed FDA, Wikidata
  • RxNorm 4952Confirmed FDA, Wikidata
  • Wikidata Q20816877thyrotropin alfaConfirmed FDA, Wikidata
  • NCI Thesaurus C61322Recombinant Thyrotropin AlfaOne source FDA
  • DrugBank DB00024One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.